Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1

Cholangiocarcinoma is a life‐threatening disease with a poor prognosis. Although genome analysis unraveled some genetic mutation profiles in cholangiocarcinoma, it remains unknown whether such genetic abnormalities relate to the effects of anticancer drugs. Mutations in isocitrate dehydrogenase 1 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Hiroaki, Tateishi, Keisuke, Kato, Hiroyuki, Nakatsuka, Takuma, Yamamoto, Keisuke, Tanaka, Yasuo, Ijichi, Hideaki, Takahara, Naminatsu, Mizuno, Suguru, Kogure, Hirofumi, Matsubara, Saburo, Nakai, Yousuke, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215870/
https://www.ncbi.nlm.nih.gov/pubmed/30156013
http://dx.doi.org/10.1111/cas.13784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215870/
https://www.ncbi.nlm.nih.gov/pubmed/30156013
http://dx.doi.org/10.1111/cas.13784

Ejemplares similares